Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
about
Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophyTrk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations.Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice.Spinal Muscular Atrophy: From Defective Chaperoning of snRNP Assembly to Neuromuscular Dysfunction.Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D miceGenetic Modifiers for Neuromuscular DiseasesGene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.Disease mechanisms and therapeutic approaches in spinal muscular atrophy.Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology.The survival motor neuron gene smn-1 interacts with the U2AF large subunit gene uaf-1 to regulate Caenorhabditis elegans lifespan and motor functions.RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns.Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cells.SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease.Fishing for causes and cures of motor neuron disorders.A simple, step-by-step dissection protocol for the rapid isolation of mouse dorsal root ganglia.The SMA Trust: the role of a disease-focused research charity in developing treatments for SMA.Two novel COLVI long chains in zebrafish that are essential for muscle development.Therapeutic strategies for spinal muscular atrophy: SMN and beyond.Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasisFree-Aspire: A new device for the management of airways clearance in patient with ineffective cough.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.HuD and the Survival Motor Neuron Protein Interact in Motoneurons and Are Essential for Motoneuron Development, Function, and mRNA Regulation.Small-molecule flunarizine increases SMN protein in nuclear Cajal bodies and motor function in a mouse model of spinal muscular atrophy.Plexin-Semaphorin Signaling Modifies Neuromuscular Defects in a Drosophila Model of Peripheral Neuropathy.Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS.Axon outgrowth and neuronal differentiation defects after a-SMN and FL-SMN silencing in primary hippocampal cultures.Accumulation of poly(A) RNA in nuclear granules enriched in Sam68 in motor neurons from the SMNΔ7 mouse model of SMA.Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy
P2860
Q30821687-0FB3DF4F-9198-409C-AA33-CB3A9D864CC5Q33594799-42FCF183-8848-4CDB-9DE5-FB31D83121D7Q33638307-C6BBE0A8-F99A-41FD-AD70-BBA6396A1851Q33700562-576D60EB-BC73-40BA-B801-C9BCDDE5B4A8Q33775770-AC974631-B7EF-4F35-8FF4-D3E5E6AC1EC7Q34394330-34E5C45A-86C3-4973-9921-C11C08220891Q35119976-364C3DB9-A5F3-433A-99C9-BE1152D94DAEQ35555633-72E5754F-B7B7-4FEF-8891-8051CC4B229EQ35707832-8AAB8AD7-4EB4-40C2-B04A-38CE68E6FDE2Q35821176-FC1DC674-5122-4F6B-96C8-724DB39F8958Q36190026-34D8B34C-ED93-42B2-BCFD-598ED787671DQ37577398-88575C9A-59A5-4320-A0CD-0A10F1800DEDQ37701253-9ED3FB89-EE02-4FB7-B2C8-F2BAC072E9DBQ38207417-CDB403C0-D89A-457C-8AA4-265C353E5361Q38224042-61D3A1FF-D2DE-434F-9312-74D9B4B02129Q38365806-D8D7719A-DEF8-44D6-8201-5F7A8A15EE16Q39340553-5F61483E-28CD-4003-B030-9CC5ABEA989FQ40547943-DEE91C99-C822-437E-951C-BEC0975968BBQ41440571-ADD90742-5CCF-4EE8-844F-42AD55B99517Q41503921-6FC06694-8014-4C20-A172-43CC6D4BA4D2Q42692236-149DF197-D69B-4FC0-862C-70AC17E9F7D8Q47152662-3A472E8F-40AC-4850-91BB-D28B1E472D2BQ47614303-6996852F-8896-4F1D-A1A3-7238060112C2Q49389328-C11BC4EE-0AD8-4D34-86F0-236F854BC3E1Q51742574-CD9C5E23-78AD-4853-A3AA-0FF32C4328BBQ55215170-20CAEA6C-4333-48E0-877C-6CE20FE22640Q55272773-CE663D68-C04E-48D9-A031-6D65E00BA7D9Q55511978-144B459A-B54F-438B-922F-9AE0E534F162Q57257404-413F3244-4FA8-43E9-A74D-0C555574614F
P2860
Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
description
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2014
@ast
im Februar 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2014/02/15)
@sk
vědecký článek publikovaný v roce 2014
@cs
wetenschappelijk artikel (gepubliceerd op 2014/02/15)
@nl
наукова стаття, опублікована в лютому 2014
@uk
مقالة علمية (نشرت في 15-2-2014)
@ar
name
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@ast
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@en
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@nl
type
label
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@ast
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@en
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@nl
prefLabel
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@ast
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@en
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Chondrolectin affects cell sur ...... els of spinal muscular atrophy
@en
P2093
Angeliki Biba
Catherina G Becker
Kay E Davies
Peter L Oliver
Thomas Becker
P2860
P304
P3181
P356
10.1093/HMG/DDT477
P577
2014-02-15T00:00:00Z